{
    "fund_name": "AMUNDI PRIME JAPAN - UCITS ETF DR",
    "type": "ETF",
    "ucits": true,
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF uses physical replication to track the Solactive GBS Japan Large & Mid Cap Index, primarily through direct investments in the underlying securities. While the KIID mentions that derivatives may be used for efficient portfolio management (e.g., handling inflows/outflows or improving index exposure), this is a standard practice for many UCITS ETFs and does not inherently make the product complex under MiFID II. The risk profile (SRRI) is moderate, and there are no indications of leverage, inverse strategies, or synthetic replication. The ETF is UCITS-compliant, which generally aligns with non-complex classifications. The absence of complex features like capital protection mechanisms, structured products, or significant counterparty risks further supports this assessment.",
    "confidence": 95,
    "counter_argument": "Some might argue that the mention of derivatives in the KIID could imply complexity. However, the context clarifies that derivatives are used only for operational efficiency (e.g., managing inflows/outflows) and not as a core strategy, which is explicitly permitted under UCITS guidelines without triggering MiFID II complexity. The physical replication method and straightforward equity exposure to Japanese large/mid-cap stocks reinforce the non-complex classification.",
    "risk_level": "Moderate (SRRI 4-5, typical for equity ETFs)"
}